Literature DB >> 20223450

Preoperative decision making for rectal cancer.

Panagiotis Taflampas1, Manousos Christodoulakis, Eelco de Bree, John Melissas, Dimitris D A Tsiftsis.   

Abstract

BACKGROUND: Rectal cancer treatment has become multimodal as a result of significant advances in imaging, staging, surgery, radiotherapy, and chemotherapy. Multidisciplinary teams can incorporate these developments into tailor-made treatment plans and offer state-of-the-art services for rectal cancer patients.
METHODS: We searched the MEDLINE and PubMed databases using the following keywords: "rectal cancer," "total mesorectal excision," "multidisciplinary treatment/team," "radiotherapy," "chemotherapy," and their combinations. There were no language or publication year restrictions. References in published articles also were reviewed.
RESULTS: Total mesorectal excision surgery, high-resolution pelvic magnetic resonance imaging, preoperative chemoradiotherapy, and pathologic reports according to Quirke protocol are preconditions for the initiation of an effective multidisciplinary team. Common topics for discussion are the status of the circumferential margin, the type of radiotherapy and surgery required, and the chemotherapeutic agent to be used.
CONCLUSIONS: This review focuses on this issue based on two main principles. First, the status of the circumferential margin dictates the use of preoperative chemoradiotherapy. Second, preoperative chemoradiotherapy is superior in terms of free circumferential resection margin rate, local recurrence rate, and toxicity. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20223450     DOI: 10.1016/j.amjsurg.2009.09.023

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

1.  CorRECTreatment: a web-based decision support tool for rectal cancer treatment that uses the analytic hierarchy process and decision tree.

Authors:  A Suner; G Karakülah; O Dicle; S Sökmen; C C Çelikoğlu
Journal:  Appl Clin Inform       Date:  2015-02-04       Impact factor: 2.342

2.  International preoperative rectal cancer management: staging, neoadjuvant treatment, and impact of multidisciplinary teams.

Authors:  Knut M Augestad; Rolv-Ole Lindsetmo; Jonah Stulberg; Harry Reynolds; Anthony Senagore; Brad Champagne; Alexander G Heriot; Fabien Leblanc; Conor P Delaney
Journal:  World J Surg       Date:  2010-11       Impact factor: 3.352

3.  Randomized clinical trial on preoperative radiotherapy 25 Gy in rectal cancer--treatment results at 5-year follow-up.

Authors:  Radoslaw Pach; Jan Kulig; Piotr Richter; Tomasz Gach; Miroslaw Szura; Teresa Kowalska
Journal:  Langenbecks Arch Surg       Date:  2011-12-15       Impact factor: 3.445

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.